Searched for
INSULIN THERAPY
In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- Health Ministry releases guidance document on Childhood Diabetes at National SummitThe Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...
- A cure for type-1 diabetes is within reach: Breakthrough stem cell therapies show promise in 2025Hope is on the horizon for Type-1 diabetes patients. New stem cell therapies are showing remarkable progress. These treatments aim to repla...
- Can type 1 diabetes be cured? Understanding causes, genetics, ongoing research, and myths about reversalType 1 diabetes is a chronic autoimmune condition. It affects millions in the US. The body's immune system destroys insulin-producing cells...
- Biocon sees GLP-1 weight-loss therapy as a future growth driverBiocon will strengthen its insulin business while advancing in GLP-1 therapies, with semaglutide in Phase-III trials and a planned 2027 Ind...
- Biocon shares surge 3% as subsidiary obtains USFDA approval for diabetes drugBiocon share price jumped after its subsidiary Biocon Biologics received USFDA approval for Kirsty, a rapid-acting insulin biosimilar. This...
- Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brandNovo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They ...
- Chinese scientists develop cure for diabetes, insulin patient becomes medicine-free in just 3 monthsChinese scientists achieve diabetes cure through innovative cell therapy, detailed in Cell Discovery. Patient, treated in July 2021, no lon...
- How insulin therapy is proving to be a boon for type-1 diabeticsHowever, improper choice of injection site, technique including reuse of needles might lead to compromised outcomes.
- Novel insulin pill to effectively manage diabetesA pill could circumvent the discomfort associated with the needle while potentially providing a more effective dose, the researchers said.
- Pharma firms ‘push’ costly insulin at patients’ expenseNewer and more expensive categories of insulin are being aggressively "pushed" by drug companies, and, hence, increasingly prescribed.
- Nutech brings in embryonic stem cell therapy for diabeticsNutech Mediworld has developed a Human Embryonic Stem Cell (HESC) therapy which will go a long way in treating patients with type-II diabet...
- Scientists prevent type I diabetes in mouse modelCurrent treatments for type I diabetes focus on controlling blood sugar with insulin therapy and must continue throughout a person's life.
Load More
